These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8836945)

  • 1. Anticholinergic therapy and dementia in patients with Parkinson's disease.
    Pondal M; Del Ser T; Bermejo F
    J Neurol; 1996 Jul; 243(7):543-6. PubMed ID: 8836945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for dementia in Parkinson's Disease - the overuse of anticholinergic drugs.
    Malkiewicz JJ; Kasprzyk AG; Waksmundzki D; Węgrzynek J; Chmiela T; Siuda J
    Neurol Neurochir Pol; 2023; 57(5):405-413. PubMed ID: 37357543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson's Disease?
    Yarnall AJ; Lawson RA; Duncan GW; Breen DP; Khoo TK; Brooks D; Barker RA; Taylor JP; Burn DJ
    J Parkinsons Dis; 2015; 5(4):743-7. PubMed ID: 26444094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticholinergic burden in Parkinson's disease inpatients.
    Lertxundi U; Isla A; Solinis MA; Domingo-Echaburu S; Hernandez R; Peral-Aguirregoitia J; Medrano J
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1271-7. PubMed ID: 26254777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study.
    Ehrt U; Broich K; Larsen JP; Ballard C; Aarsland D
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):160-5. PubMed ID: 19770163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confusion, dementia and anticholinergics in Parkinson's disease.
    de Smet Y; Ruberg M; Serdaru M; Dubois B; Lhermitte F; Agid Y
    J Neurol Neurosurg Psychiatry; 1982 Dec; 45(12):1161-4. PubMed ID: 7161613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription patterns of anticholinergic agents and their associated factors in Korean elderly patients with dementia.
    Lee EK; Lee YJ
    Int J Clin Pharm; 2013 Oct; 35(5):711-8. PubMed ID: 23708883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and patterns of the concurrent use of anticholinergics for the motor symptoms of Parkinson's disease and acetylcholinesterase inhibitors in Parkinson's disease patients with dementia: a cross-sectional study using Korea National Health Insurance claims data.
    Baik D; Yu YM; Jung SY; Kang HY
    BMC Geriatr; 2022 Jul; 22(1):609. PubMed ID: 35864474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia.
    Zoccolella S; dell'Aquila C; Abruzzese G; Antonini A; Bonuccelli U; Canesi M; Cristina S; Marchese R; Pacchetti C; Zagaglia R; Logroscino G; Defazio G; Lamberti P; Livrea P
    Mov Disord; 2009 May; 24(7):1028-33. PubMed ID: 19353704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome.
    Bédard MA; Pillon B; Dubois B; Duchesne N; Masson H; Agid Y
    Brain Cogn; 1999 Jul; 40(2):289-313. PubMed ID: 10413563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.
    Riedel O; Heuser I; Klotsche J; Dodel R; Wittchen HU;
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):27-34. PubMed ID: 20042544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medical treatment of Parkinson's disease].
    Waldvogel D
    Ther Umsch; 2007 Jan; 64(1):15-20. PubMed ID: 17221820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cognitive dysfunction in patients with Parkinson's disease].
    Zakharov VV; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):13-9. PubMed ID: 15704477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic activity and cognitive decline in Parkinson's disease.
    Starkstein SE
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):129. PubMed ID: 20145024
    [No Abstract]   [Full Text] [Related]  

  • 15. The evolution of dementia in idiopathic Parkinson's disease: neuropsychological and clinical evidence in support of subtypes.
    Reid WG
    Int Psychogeriatr; 1992; 4 Suppl 2():147-60. PubMed ID: 1288660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dementia in Parkinson Disease.
    Lieberman A; Dziatolowski M; Kupersmith M; Serby M; Goodgold A; Korein J; Goldstein M
    Ann Neurol; 1979 Oct; 6(4):355-9. PubMed ID: 554525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring anticholinergic exposure in patients with dementia: A comparative study of nine anticholinergic risk scales.
    Turró-Garriga O; Calvó-Perxas L; Vilalta-Franch J; Blanco-Silvente L; Castells X; Capellà D; Garre-Olmo J;
    Int J Geriatr Psychiatry; 2018 May; 33(5):710-717. PubMed ID: 29292848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Parkinson's disease: what is the best approach to treatment.
    Hristova AH; Koller WC
    Drugs Aging; 2000 Sep; 17(3):165-81. PubMed ID: 11043817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Initial treatment of Parkinson's disease].
    Kulisevsky J; López-Villegas D
    Rev Neurol; 1997 Aug; 25 Suppl 2():S163-9. PubMed ID: 9280684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dementia and lower urinary dysfunction: with a reference to anticholinergic use in elderly population.
    Sakakibara R; Uchiyama T; Yamanishi T; Kishi M
    Int J Urol; 2008 Sep; 15(9):778-88. PubMed ID: 18643858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.